Symbiomix Therapeutics

Late stage biopharma developing antibiotics to treat gynecological infections

placeNewark, New Jersey, United States calendar_todayFounded 2012 groups11 employees language symbiomix.com

Innovation

4 patent families (2 granted) — focus: Human necessities; filing pace slowing. Cited 160 times.

YearFilings
20131
20162
20171
20181
20192
20203
20221
20231

Investor mix

5 investors on record; 2 have since exited.

Investor typeCountShare
Venture capital360%
Private equity120%
Other / undisclosed120%
Coming soon